https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cci-clears-berhyandas-acquisition-of-suven-pharma/articleshow/99647214.cms
0
0
51 words
0
Comments
The acquisition is “by way of a share purchase agreement of December 26, 2022 and pursuant to the mandatory open offer in compliance with the Securities and Exchange Board of India (SEBI) (Substantial Acquisition of Shares and Takeovers) Regulations, 2011”, t…
You are the first to view
Create an account or login to join the discussion